Just a few years ago, vitamin D was simply known as the “bone vitamin,” and even today many physicians still believe it essential only for bone health.
Research shows otherwise, however: insufficient vitamin D levels increases the risk of many types of disease, including osteoporosis, heart disease, stroke, some cancers, type 1 diabetes, multiple sclerosis, tuberculosis and even the flu, but in this article we’re going to focus on the positive.
That is, we’re going to look at some of vitamin D’s amazing benefits and why I believe it’s one supplement that just about everyone should be taking every day.
So let’s see what the literature says about vitamin D’s benefits.
Table of Contents
As I noted earlier, it was once believed that maintaining optimal vitamin D levels was only for bone health.
Well, thanks to the hard work of many scientists, including the notable Dr. Michael Holick, we now know that nearly every type of tissue and cell in the body has vitamin D receptors, which means its actually an essential hormone that plays a vital role in a large number of physiological processes.
When we ingest vitamin D or produce it in the skin (as a result of sun exposure), it gets converted into its active form, 1 ,25-dihydroxyvitamin D, or vitamin D3. This substance then interacts with and supports virtually every tissue type in your body, including your heart, brain, and even fat cells. Furthermore, research has demonstrated that vitamin D also regulates genes that control immune function, metabolism, and even cell growth and development.
As you can see, this vitamin deserves a lot more attention than it has been given over the last couple of decades. Fortunately, however, vitamin D’s vital importance and amazing benefits are becoming more and more widely known and accepted.
Let’s look at five of these benefits now.
In this study, researchers measured vitamin D levels of 1783 healthy middle-aged subjects (964 men and 819 women) and found that women with vitamin D levels in the top one-third of the subjects analyzed had 68% lower risk of heart attack compared with those in the bottom one-third. In men, researchers found 44% lower risk in the upper third compared to the lower.
The reason vitamin D levels play such a big role in cardiovascular health is heart muscle and the circulatory system are teeming with vitamin D receptors, which indicates how much they rely on this hormone for maintaining optimal health and function.
Thus, it’s not surprising that research has demonstrated that supplementation with adequate amounts of vitamin D improves heart health in various ways:
- It reduces triglycerides in the blood, which are a type of fat that can increase your risk of heart disease if your levels become too high
- It improves blood pressure and blood flow by relaxing the blood vessels
- It improves function of the endothelium, which is a thin layer of cells that lines the interior surface of blood vessels and lymphatic vessels
- It improves your cholesterol profile
The research is clear: maintaining optimal levels of vitamin D has a profound effect on heart and circulatory health.
Simply ensuring you have sufficient vitamin D in your blood dramatically reduces your risk of developing type II diabetes, but research shows it can even benefit those struggling with insulin-related problems (including those with the disease).
For instance, in this study, diabetic adults supplemented with 2,000 IU of vitamin D per day for 16 weeks and displayed dramatically improved glucose control, insulin response, and hemoglobin A1c levels. This study demonstrated similar results with 1,000 IU per day.
Preserving insulin sensitivity not only helps maintain optimal overall health but also helps with building muscle. Research shows that vitamin D even has other muscle-building properties: it magnifies the muscle-building effects of leucine, which is why I take mine with my post-workout meal.
Research shows that insufficient vitamin D levels dramatically increases the risk of cognitive decline, including Alzheimer’s disease and non-Alzheimer’s dementia.
This is because the brain is replete with vitamin D receptors and relies on the hormone to combat various destructive processes. Furthermore, vitamin D plays a vital role in growing new nerve cells, transmission of nerve impulses, and maintaing “brain plasticity,” which is vital for functions related to learning and memory.
Vitamin D is so powerful in the brain that research shows it can even reverse the neurodegenerative decline associated with Alzheimer’s disease and prevent deterioration in Parkinson’s disease patients.
These correlations are due to the fact that vitamin D receptors regulate a number of processes related to the immune response to cancer cells, tumor growth, and inflammation.
The anti-carcinogenic powers of vitamin D can be seen in studies that demonstrated vitamin D supplementation reduces the tumor-promoting effects of estrogen, decreases the incidence of prostate cancer tumors, and decreases levels of the tumor-promoting protein beta-catenin while increasing the tumor-suppressing protein known as APC.
Immune cells rely on vitamin D to regulate how they respond to threats in the body, first by attacking and destroying, followed by “cleaning up” and returning to a state of dormant readiness.
It’s estimated that nearly 1 billion people have inadequate vitamin D levels for supporting optimal health. (Click here to tweet this!) Yikes!
According to current medical standards, there are three levels of vitamin D status as determined by blood testing:
- Sufficient means you have at least 30 nanograms of vitamin D per milliliter of blood (ng/mL)
- Insufficient means you have vitamin D levels between 21 and 29 ng/mL)
- Deficient means you have levels at or below 20 ng/mL
Research shows that 25% of Americans have insufficient levels of vitamin D and 39% are deficient, which means a surprising 64% of Americans have inadequate levels of vitamin D.
What gives? Why are do so many people have low levels of vitamin D?
Well, a major reason for this is the fact that it’s very tough to get adequate amounts of vitamin D from the diet alone, and unless you have time to sunbathe every day, your only option is supplementation. But we’ll get to that in a minute.
According to the Institute of Medicine, 600 IU per day is adequate for ages 1-70 (and 800 IU per day for 71+), but these numbers have been severely criticized by scientists that specialized in vitamin D research. They call attention to the over 125 peer-reviewed studies that indicate such recommendations are too low, and are likely to lead to vitamin D deficiencies.
A committee of the U.S. Endocrine Society recently convened to review the evidence, and concluded that 600-1,000 IU per day is adequate for ages 1-18, and 1,500-2,000 IU per day is adequate for ages 19+.
According to Dr. Michael Holick, however, 2,000 IU per day is suboptimal. Research shows that 2,000 IU per day is the minimum needed to maintain vitamin D sufficiency (30 ng/mL), but Dr. Holick maintains that optimal vitamin D status is actually between 50 and 80 ng/mL, which would call for a daily intake closer to 5,000 IU.
Considering the fact that overdosing isn’t likely to occur until intake skyrockets to 40,000 IU per day for several months, or 300,000 IU in a 24-hour period, these are very safe recommendations.
So, I recommend you start at 2,000 IU per day and then get blood tested for your 25-hydroxyvitamin D levels (the usable form of vitamin D your body creates) to ascertain your vitamin D status.
Chances are you’ll come in below 50 to 80 ng/mL and research shows that you need to increase intake of vitamin D by 100 IU to increase blood concentration by1 ng/mL. For instance, if your test came back at 30 ng/mL and you wanted to raise it to 50 ng/mL, you would need to increase your current intake by 2,000 IU.
As you may know, our body can’t produce enough vitamin D to maintain adequate levels–we have to get additional amounts from our diet, sun exposure, or supplementation. Let’s look at each of these sources separately.
Vitamin D is hard to come by in nature. You find very small amounts in various foods like beef liver, cheese, and egg yolks, and slightly larger amounts in fatty fish like salmon, tuna, and mackerel, which have anywhere from 50 to 150 IU per ounce. Cod liver oil is by far the best food source with over 1,300 IU per tablespoon.
You’ll find vitamin D added to various “fortified” foods like milk, breakfast cereals, orange juice, and margarine, but reaching an adequate intake of vitamin D through these foods alone isn’t feasible if you’re trying to follow a sensible meal plan.
Now, when our skin is exposed to UVB rays, they interact with a form of cholesterol in the body to produce vitamin D. The more skin that is exposed to the sun, and the stronger its rays, the more vitamin D you produce.
Research has shown that, with 25% of our skin exposed, our bodies can produce upwards of 400 IUs of vitamin D in just 3-6 minutes of exposure to the 12 PM Florida sun. As you can see, however, reaching optimal levels would require anywhere from 30 to 60 minutes of sunbathing per day. And ain’t nobody got time for that. 😉
This is why I recommend you simply supplement with vitamin D. It’s cheap, effective, and gives you maximum flexibility in your diet (personally I’m not a fan of salmon, mackerel, or beef liver).
Here’s the supplement I take:
If you prefer to stick with a food-based source of vitamin D, I recommend the following cod liver oil:
If you’d like to learn more about vitamin D and what the latest scientific research is revealing, I highly recommend Dr. Michael Holick’s book:
What do you think of vitamin D’s benefits? Have anything else to share? Let me know in the comments below!
+ Scientific References
- F. Holick, M. (2010). Vitamin D: Evolutionary, Physiological and Health Perspectives. Current Drug Targets, 12(1), 4–18. https://doi.org/10.2174/138945011793591635
- Vieth, R. (1999). Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. In American Journal of Clinical Nutrition (Vol. 69, Issue 5, pp. 842–856). American Society for Nutrition. https://doi.org/10.1093/ajcn/69.5.842
- Tran, B., Armstrong, B. K., Carlin, J. B., Ebeling, P. R., English, D. R., Kimlin, M. G., Rahman, B., Van Der Pols, J. C., Venn, A., Gebski, V., Whiteman, D. C., Webb, P. M., & Neale, R. E. (2012). Recruitment and results of a pilot trial of vitamin D supplementation in the general population of Australia. Journal of Clinical Endocrinology and Metabolism, 97(12), 4473–4480. https://doi.org/10.1210/jc.2012-2682
- Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011). Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. In Journal of Clinical Endocrinology and Metabolism (Vol. 96, Issue 7, pp. 1911–1930). J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2011-0385
- Heaney, R. P., & Holick, M. F. (2011). Why the IOM recommendations for vitamin D are deficient. In Journal of Bone and Mineral Research (Vol. 26, Issue 3, pp. 455–457). J Bone Miner Res. https://doi.org/10.1002/jbmr.328
- Ross, A. C., Manson, J. A. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., Kovacs, C. S., Mayne, S. T., Rosen, C. J., & Shapses, S. A. (2011). The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. In Journal of Clinical Endocrinology and Metabolism (Vol. 96, Issue 1, pp. 53–58). Endocrine Society. https://doi.org/10.1210/jc.2010-2704
- Mitchell, D. M., Henao, M. P., Finkelstein, J. S., & Burnett-Bowie, S. A. M. (2012). Prevalence and predictors of vitamin D deficiency in healthy adults. Endocrine Practice, 18(6), 914–923. https://doi.org/10.4158/EP12072.OR
- Mesliniene, S., Ramrattan, L., Giddings, S., & Sheikh-Ali, M. (2013). Role of vitamin D in the onset, progression, and severity of multiple sclerosis. In Endocrine Practice (Vol. 19, Issue 1, pp. 129–136). Endocr Pract. https://doi.org/10.4158/EP12152.RA
- Z Andjelkovic, J Vojinovic, N Pejnovic, M Popovic, A Dujic, D Mitrovic, L Pavlica, & D Stefanovic. (n.d.). Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients - PubMed. Retrieved June 24, 2021, from https://pubmed.ncbi.nlm.nih.gov/10464556/
- Amital, H., Szekanecz, Z., Szücs, G., Dankó, K., Nagy, E., Csépány, T., Kiss, E., Rovensky, J., Tuchynova, A., Kozakova, D., Doria, A., Corocher, N., Agmon-Levin, N., Barak, V., Orbach, H., Zandman-Goddard, G., & Shoenfeld, Y. (2010). Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D? Annals of the Rheumatic Diseases, 69(6), 1155–1157. https://doi.org/10.1136/ard.2009.120329
- Zipitis, C. S., & Akobeng, A. K. (2008). Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. In Archives of Disease in Childhood (Vol. 93, Issue 6, pp. 512–517). Arch Dis Child. https://doi.org/10.1136/adc.2007.128579
- Bouillon, R., Carmeliet, G., Verlinden, L., Van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., & Demay, M. (2008). Vitamin D and human health: Lessons from vitamin D receptor null mice. In Endocrine Reviews (Vol. 29, Issue 6, pp. 726–776). Endocr Rev. https://doi.org/10.1210/er.2008-0004
- Ahearn, T. U., Shaukat, A., Flanders, W. D., Rutherford, R. E., & Bostick, R. M. (2012). A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients. Cancer Prevention Research, 5(10), 1247–1256. https://doi.org/10.1158/1940-6207.CAPR-12-0292
- Marshall, D. T., Savage, S. J., Garrett-Mayer, E., Keane, T. E., Hollis, B. W., Horst, R. L., Ambrose, L. H., Kindy, M. S., & Gattoni-Celli, S. (2012). Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. Journal of Clinical Endocrinology and Metabolism, 97(7), 2315–2324. https://doi.org/10.1210/jc.2012-1451
- Krishnan, A. V., Swami, S., & Feldman, D. (2012). The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer. In Steroids (Vol. 77, Issue 11, pp. 1107–1112). Steroids. https://doi.org/10.1016/j.steroids.2012.06.005
- Moukayed, M., & Grant, W. B. (2013). Molecular link between vitamin D and cancer prevention. In Nutrients (Vol. 5, Issue 10, pp. 3993–4021). MDPI AG. https://doi.org/10.3390/nu5103993
- Amaral, A. F. S., Méndez-Pertuz, M., Muñoz, A., Silverman, D. T., Allory, Y., Kogevinas, M., Lloreta, J., Rothman, N., Carrato, A., Rivas Del Fresno, M., Real, F. X., & Malats, N. (2012). Plasma 25-Hydroxyvitamin D3 and bladder cancer risk according to tumor stage and FGFR3 status: A mechanism-based epidemiological study. Journal of the National Cancer Institute, 104(24), 1897–1904. https://doi.org/10.1093/jnci/djs444
- Michael Roskies, Yalon Dolev, Derin Caglar, Michael P Hier, Alex Mlynarek, Agnieszka Majdan, & Richard J Payne. (n.d.). Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer - PubMed. Retrieved June 24, 2021, from https://pubmed.ncbi.nlm.nih.gov/22762696/
- Bilinski, K., & Boyages, J. (2013). Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: An observational case-control study. Breast Cancer Research and Treatment, 137(2), 599–607. https://doi.org/10.1007/s10549-012-2381-1
- Suzuki, M., Yoshioka, M., Hashimoto, M., Murakami, M., Noya, M., Takahashi, D., & Urashima, M. (2013). Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. American Journal of Clinical Nutrition, 97(5), 1004–1013. https://doi.org/10.3945/ajcn.112.051664
- Annweiler, C., Herrmann, F. R., Fantino, B., Brugg, B., & Beauchet, O. (2012). Effectiveness of the combination of memantine plus vitamin d on cognition in patients with Alzheimer disease: A pre-post pilot study. Cognitive and Behavioral Neurology, 25(3), 121–127. https://doi.org/10.1097/WNN.0b013e31826df647
- Deluca, G. C., Kimball, S. M., Kolasinski, J., Ramagopalan, S. V., & Ebers, G. C. (2013). Review: The role of vitamin D in nervous system health and disease. In Neuropathology and Applied Neurobiology (Vol. 39, Issue 5, pp. 458–484). Neuropathol Appl Neurobiol. https://doi.org/10.1111/nan.12020
- Soni, M., Kos, K., Lang, I. A., Jones, K., Melzer, D., & Llewellyn, D. J. (2012). Vitamin D and cognitive function. Scandinavian Journal of Clinical and Laboratory Investigation, 72(SUPPL. 243), 79–82. https://doi.org/10.3109/00365513.2012.681969
- Annweiler, C., Rolland, Y., Schott, A. M., Blain, H., Vellas, B., & Beauchet, O. (2012). Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: A 7-year longitudinal study. Dementia and Geriatric Cognitive Disorders, 32(4), 273–278. https://doi.org/10.1159/000334944
- Salles, J., Chanet, A., Giraudet, C., Patrac, V., Pierre, P., Jourdan, M., Luiking, Y. C., Verlaan, S., Migné, C., Boirie, Y., & Walrand, S. (2013). 1,25(OH)2-vitamin D3 enhances the stimulating effect of leucine and insulin on protein synthesis rate through Akt/PKB and mTOR mediated pathways in murine C2C12 skeletal myotubes. Molecular Nutrition and Food Research, 57(12), 2137–2146. https://doi.org/10.1002/mnfr.201300074
- Nikooyeh, B., Neyestani, T. R., Farvid, M., Alavi-Majd, H., Houshiarrad, A., Kalayi, A., Shariatzadeh, N., Gharavi, A., Heravifard, S., Tayebinejad, N., Salekzamani, S., & Zahedirad, M. (2011). Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: A randomized clinical trial. American Journal of Clinical Nutrition, 93(4), 764–771. https://doi.org/10.3945/ajcn.110.007336
- Mitri, J., Dawson-Hughes, B., Hu, F. B., & Pittas, A. G. (2011). Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: The Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. American Journal of Clinical Nutrition, 94(2), 486–494. https://doi.org/10.3945/ajcn.111.011684
- Huang, Y., Li, X., Wang, M., Ning, H., A, L., Li, Y., & Sun, C. (2013). Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: A cross-sectional epidemiological study. Cardiovascular Diabetology, 12(1). https://doi.org/10.1186/1475-2840-12-17
- Salehpour, A., Shidfar, F., Hosseinpanah, F., Vafa, M., Razaghi, M., Hoshiarrad, A., & Gohari, M. (2012). Vitamin D3 and the risk of CVD in overweight and obese women: A randomised controlled trial. British Journal of Nutrition, 108(10), 1866–1873. https://doi.org/10.1017/S0007114512000098
- Harris, R. A., Pedersen-White, J., Guo, D. H., Stallmann-Jorgensen, I. S., Keeton, D., Huang, Y., Shah, Y., Zhu, H., & Dong, Y. (2011). Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. American Journal of Hypertension, 24(5), 557–562. https://doi.org/10.1038/ajh.2011.12
- Zittermann, A., Frisch, S., Berthold, H. K., Götting, C., Kuhn, J., Kleesiek, K., Stehle, P., Koertke, H., & Koerfer, R. (2009). Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. American Journal of Clinical Nutrition, 89(5), 1321–1327. https://doi.org/10.3945/ajcn.2008.27004
- Pilz, S., Tomaschitz, A., März, W., Drechsler, C., Ritz, E., Zittermann, A., Cavalier, E., Pieber, T. R., Lappe, J. M., Grant, W. B., Holick, M. F., & Dekker, J. M. (2011). Vitamin D, cardiovascular disease and mortality. In Clinical Endocrinology (Vol. 75, Issue 5, pp. 575–584). Clin Endocrinol (Oxf). https://doi.org/10.1111/j.1365-2265.2011.04147.x
- Sun, Q., Pan, A., Hu, F. B., Manson, J. E., & Rexrode, K. M. (2012). 25-hydroxyvitamin D levels and the risk of stroke: A prospective study and meta-analysis. Stroke, 43(6), 1470–1477. https://doi.org/10.1161/STROKEAHA.111.636910
- Wang, L., Song, Y., Manson, J. A. E., Pilz, S., März, W., Michaëlsson, K., Lundqvist, A., Jassal, S. K., Barrett-Connor, E., Zhang, C., Eaton, C. B., May, H. T., Anderson, J. L., & Sesso, H. D. (2012). Circulating 25-Hydroxy-Vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circulation: Cardiovascular Quality and Outcomes, 5(6), 819–829. https://doi.org/10.1161/CIRCOUTCOMES.112.967604
- Karakas, M., Thorand, B., Zierer, A., Huth, C., Meisinger, C., Roden, M., Rottbauer, W., Peters, A., Koenig, W., & Herder, C. (2013). Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: Results from the MONICA/KORA Augsburg case-cohort study. Journal of Clinical Endocrinology and Metabolism, 98(1), 272–280. https://doi.org/10.1210/jc.2012-2368
- Artaza, J. N., & Norris, K. C. (2009). Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. Journal of Endocrinology, 200(2), 207–221. https://doi.org/10.1677/JOE-08-0241
- Pilz, S., Tomaschitz, A., Drechsler, C., Dekker, J. M., & März, W. (2010). Vitamin D deficiency and myocardial diseases. In Molecular Nutrition and Food Research (Vol. 54, Issue 8, pp. 1103–1113). Mol Nutr Food Res. https://doi.org/10.1002/mnfr.200900474
- Wacker, M., & Holiack, M. F. (2013). Vitamin D-effects on skeletal and extraskeletal health and the need for supplementation. In Nutrients (Vol. 5, Issue 1, pp. 111–148). MDPI AG. https://doi.org/10.3390/nu5010111
- Cannell, J. J., Vieth, R., Umhau, J. C., Holick, M. F., Grant, W. B., Madronich, S., Garland, C. F., & Giovannucci, E. (2006). Epidemic influenza and vitamin D. In Epidemiology and Infection (Vol. 134, Issue 6, pp. 1129–1140). Epidemiol Infect. https://doi.org/10.1017/S0950268806007175
- Nnoaham, K. E., & Clarke, A. (2008). Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis. In International Journal of Epidemiology (Vol. 37, Issue 1, pp. 113–119). Oxford University Press. https://doi.org/10.1093/ije/dym247
- Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006). Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Journal of the American Medical Association, 296(23), 2832–2838. https://doi.org/10.1001/jama.296.23.2832
- Hyppönen, E., Läärä, E., Reunanen, A., Järvelin, M. R., & Virtanen, S. M. (2001). Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet, 358(9292), 1500–1503. https://doi.org/10.1016/S0140-6736(01)06580-1
- Giovannucci, E. (2007). Epidemiological evidence for vitamin D and colorectal cancer. Journal of Bone and Mineral Research, 22(SUPPL. 2). https://doi.org/10.1359/jbmr.07s206
- Pilz, S., Dobnig, H., Fischer, J. E., Wellnitz, B., Seelhorst, U., Boehm, B. O., & März, W. (2008). Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke, 39(9), 2611–2613. https://doi.org/10.1161/STROKEAHA.107.513655
- Wang, T. J., Pencina, M. J., Booth, S. L., Jacques, P. F., Ingelsson, E., Lanier, K., Benjamin, E. J., D’Agostino, R. B., Wolf, M., & Vasan, R. S. (2008). Vitamin D deficiency and risk of cardiovascular disease. Circulation, 117(4), 503–511. https://doi.org/10.1161/CIRCULATIONAHA.107.706127
- Dawson-Hughes, B., Mithal, A., Bonjour, J. P., Boonen, S., Burckhardt, P., Fuleihan, G. E. H., Josse, R. G., Lips, P., Morales-Torres, J., & Yoshimura, N. (2010). IOF position statement: Vitamin D recommendations for older adults. Osteoporosis International, 21(7), 1151–1154. https://doi.org/10.1007/s00198-010-1285-3